A neuropathology that involves TNFα-mediated neuroinflammation and Pgrmc1 signaling is Alzheimer’s disease (AD), a progressive neurological disease that results in cognitive impairment and memory loss. This evidence concerns the gene PGRMC1 and nervous system disorder.